STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended		53 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (488,104)	$ (596,628)	$ (3,863,903)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	16,249	16,249	119,164
Allowance for uncollectible notes receivable	13,867	0	38,867
Amortization of deferred finance costs	1,252	685	33,492
Interest (income) expense on fair value adjustment on convertible notes payable	(18,279)	45,599	170,370
Interest accrued on note receivable	0	0	(11,705)
Write off of uncollectible deposit	0	0	20,000
Loss on extinguishment of related party debt	0	41,500	46,120
Loss on impairment	21,000	0	21,000
Stock issued for services	72,651	249,355	1,219,344
Changes in operating assets and liabilities:
Deposits and other receivables	(44,084)	(1,281)	(67,430)
Accounts payable and accrued liabilities	127,910	(68,469)	338,617
Net cash used in operating activities	(297,538)	(312,990)	(1,936,064)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net proceeds from notes receivable	0	0	(25,000)
Purchase of securities	(21,000)	0	(22,100)
Acquisition of equipment	0	0	(325,000)
Net cash provided by (used in) investing activities	(21,000)	0	(372,100)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	178,670	179,695	1,670,642
Proceeds from the issuance of convertible notes, related parties	0	168,500	6,000
Proceeds from the issuance of convertible notes, non related parties	20,000	0	438,300
Proceeds from the issuance of notes payable	155,000	20,000	271,500
Proceeds from the issuance of notes payable, related parties	5,000	0	5,000
Payments on convertible notes payable	(25,000)	0	(35,000)
Payments on notes payable	0	(5,000)	(40,000)
Proceeds from loans from stockholders	0	0	35,925
Payments on loans from stockholders	(5,225)	(26,000)	(31,225)
Net cash provided by financing activities	328,445	337,195	2,321,142
NET INCREASE IN CASH	9,907	24,205	12,978
CASH, BEGINNING OF PERIOD	3,071	1,015	0
CASH, END OF PERIOD	12,978	25,220	12,978
NONCASH FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital	0	0	91,500
Common stock issued for loan financing fees	1,250	5,000	6,250
Common stock issued to satisfy minimum value guarantee	0	0	87,667
Convertible debt converted to common stock including accrued interest	32,766	182,212	470,504
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	$ 0	$ 0	$ 3,660